Abstract
Monoamine oxidase activity during deamination of serotonin and dopamine in the amygdaloid complex, hippocampus, striatum and prefrontal cortex of the brain was studied at different stages in the formation of latent inhibition, acquired by rats on the basis of a conditioned passive avoidance reaction. Latent inhibition is a behavioral phenomenon consisting of a worsening in learning using a stimulus when attention to this stimulus is quenched before acquisition of the conditioned response. At the stage of preliminary repeated presentation of the conditioned stimulus, serotonin metabolism was seen to change in the amygdaloid complex and striatum, while dopamine metabolism changed in the amygdaloid complex and hippocampus. Metabolic shifts in transmitter handling during quenching of attention to the stimulus occurred in the opposite directions: the serotonin-deaminating activity of monoamine oxidase increased, while the dopamine-deaminating activity of the enzyme decreased. Unlike the reaction to the quenched stimulus, the latent inhibition effect, seen on testing the conditioned response after conditioning of the pre-exposed stimulus with unconditioned reinforcement, was accompanied by changes in serotoninergic activity only. High levels of serotonin deamination by monoamine oxidase were seen in the amygdaloid complex and striatum. In addition, there was a reduction in serotonin deamination in the prefrontal cortex specific for the stage of testing latent inhibition. At the same time, dopamine metabolism did not change in any of the brain structures studied in latent inhibition. These data lead to the conclusion that the latent inhibition effect may be based on increases in serotoninergic activity in subcortical brain structures – the amygdaloid complex and the striatum – induced by reactions to presentation of the quenched stimulus.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
REFERENCES
V. Z. Gorkin, Amine Oxidases and Their Importance in Medicine, [in Russian], Meditsina, Moscow (1981).
L. V. Loskutova, “Latent inhibition in rats and mice in conditioned passive avoidance responses,” Zh. Vyssh. Nerv. Deyat., 35, No. 6, 1172–1174 (1985).
L. V. Loskutova, F. Ya. Luk'yanenko, and R. Yu. Il'yuchenok, “Interaction of the serotonin-and dopaminergic systems of the brain in the mechanisms of latent inhibition in rats,” Zh. Vyssh. Nerv. Deyat., 39, No. 4, 714–720 (1989).
F. Ya. Luk'yanenko, L. V. Loskutova, and R. Yu. Il'yuchenok, “The role of serotoninergic terminals in the hippocampus and frontal cortex in the neurochemical mechanisms of latent inhibition in rats,” Izv. Sib. Otd. Ross. Akad. Med. Nauk, No. 2, 14–19 (1992).
G. K. Aghajanian, “Electrophysiology of serotonin receptor subtypes and signal transduction pathways,” in: Psychopharmacology: The Fourth Generation of Progress, F. E. Bloom and D. J. Kupfer (eds.), Raven Press, New York (1995), pp. 451–460.
M. H. Bagshaw, D. P. Kimble, and K. H. Pribram, “The GSR of monkeys during orienting and habituation and after ablation of the amygdala, hippocampus and inferotemporal cortex,” Neuropsychologia, 3, 111–119 (1965).
L. M. Broersen, J. Feldon, and I. Weiner, “Dissociative effects of apomorphine infusions into the medial prefrontal cortex of rats on latent inhibition, prepulse inhibition and amphetamine-induced locomotion,” Neurosci., 94, 39–46 (1999).
L. H. Burns, L. Annett, A. E. Kelley, et al., “Effects of lesions to amygdala, ventral subiculum, medial prefrontal cortex, and nucleus accumbens on the reaction to novelty: Implications for limbic-striatal interactions,” Behav. Neurosci., 110, 60–73 (1996).
H. J. Cassaday, H. Hodges, and J. A. Gray, “The effects of ritanserin, RU 24969 and 8-OH-DPAT on latent inhibition in the rat,” J. Psychopharmacol., 7, 63–71 (1993).
H. J. Cassaday, S. N. Mitchell, J. H. Williams, and J. A. Gray, “5,7-Dihydroxytryptamine lesions in the fornix-fimbria attenuate latent inhibition,” Behav. Neurol. Biol., 59, 194–207 (1993).
L.-L. Cheng, S.-J. Wang, and P.-W. Gean, “Serotonin depresses excitatory synaptic transmission and depolarization-evoked Ca2+ influx in rat basolateral amygdala via 5-HT1A receptors,” Eur. J. Neurosci., 10, 2163–2172 (1998).
S. A. Deadwyler and E. J. Wyers, “Disruption of habituation by caudate nucleus stimulation in the rat,” Behav. Biol., 7, 55–64 (1972).
B. A. Ellenbroek, S. Budde, and A. R. Cools, “Prepulse inhibition and latent inhibition: the role of dopamine in the medial prefrontal cortex,” Neurosci., 75, 535–542 (1996).
B. A. Ellenbroek, D. A. Knobbout, and A. R. Cools, “The role of mesolimbic and nigrostriatal dopamine in latent inhibition as measured with the conditioned taste aversion paradigm,” Psychopharmacol., 129, 112–120 (1997).
J. Feldon, A. Shoel, and I. Weiner, “Latent inhibition is unaffected by direct dopamine agonists,” Pharmacol. Biochem. Behav., 38, 309–314 (1991).
M. Gallo and A. Candido, “Dorsal hippocampal lesions impair blocking but not latent inhibition of taste aversion learning in rats,” Behav. Neurosci., 109, 413–425 (1995).
J. A. Gray, M. H. Joseph, D. R. Hemsley, et al., “The role of mesolimbic dopaminergic and retrohippocampal afferents to the nucleus accumbens in latent inhibition: implications for schizophrenia,” Behav. Brain Res., 71, 19–31 (1995).
J. M. Hitchcock, S. Lister, T. R. Fischer, and J. G. Wettstein, “Disruption of latent inhibition in the rat by the 5-HT2A agonist DOI: effects of MDL100,907, clozapine, risperidone and haloperidol,” Behav. Brain Res., 88, 43–49 (1997).
M. E. Jarvic and R. Kopp, “An improved one-trial passive avoidance learning situation,” Physiol. Rep., 21, 221–224 (1967).
A. R. Kilcross and T. W. Robbins, “Differential effects of intra-accumbens and systemic amphetamine on latent inhibition using an on-baseline, within-subject conditioned suppression paradigm,” Psychopharmacology, 110, 479–489 (1993).
A. S. Kilcross, K. J. Stanhope, C. T. Dourish, and G. Piras, “WAY100635 and latent inhibition in the rat: selective effects at preexposure,” Behav. Brain Res., 88, 51–57 (1997).
J. F. R. König and R. Klippel, The Rat Brain. A Stereotaxic Atlas of the Forebrain and Lower Parts of the Brain Stem, Baltimore (1963).
M. Konstandi and E. Kafetzopoulos, “Effects of striatal or accumbens lesions on the amphetamine-induced abolition of latent inhibition,” Pharmacol. Biochem. Behav., 44, 751–754 (1993).
L. Lacroix, L. M. Broersen, J. Feldon, and I. Weiner, “Effects of local infusions of dopaminergic drugs into the medial prefrontal cortex of rats on latent inhibition, prepulse inhibition, and amphetamine-induced activity,” Behav. Brain Res., 107, 111–121 (2000).
L. Lacroix, L. M. Broersen, I. Weiner, and J. Feldon, “The effects of excitotoxic lesion of the medial prefrontal cortex on latent inhibition, prepulse inhibition, food hoarding, elevated plus maze, active avoidance and locomotor activity in the rat,” Neurosci., 82, 431–442 (1998).
J. F. Lorden, E. J. Rickert, and D. W. Berry, “Forebrain monoamines and associative learning: I. Latent inhibition and conditioned inhibition,” Behav. Brain Res., 9, 181–199 (1983).
R. E. Lubow, Latent Inhibition and Conditioned Attention Theory, Cambridge University Press, Cambridge (1989).
G. F. Molodtsova and R. Yu. Il'uchenok, “Pre-and postsynaptic mechanisms of the involvement of amygdaloid complex serotonin in the reproduction of a conditioned passive avoidance response in rats,” Neurosci. Behav. Physiol., 29, 359–363 (1999).
P. D. Mora, N. Fouquet, P. Oberling, et al., “A neurotoxic lesion of serotonergic neurones using 5,7-dihydroxytryptamine does not disrupt latent inhibition in paradigms sensitive to low doses of amphetamine,” Behav. Brain Res., 100, 167–175 (1999).
P. M. Moran and P. C. Moser, “MDL73,147EF, a 5-HT3 antagonist, facilitates latent inhibition in the rat,” Pharmacol. Biochem. Behav., 42, 518–522 (1992).
A. Pazos and J. M. Palacios, “Quantitative autoradiographic mapping of serotonin receptors in the rat brain. I. Serotonin-1 receptors,” Brain Res., 346, 205–230 (1985).
D. Purves, C. Bonardi, and G. Hall, “Enhancement of latent inhibition in rats with electrolytic lesions of the hippocampus,” Behav. Neurosci., 109, 366–370 (1995).
E. Sakurai, S. Yamasaki, H. Niwa, et al., “Relation between serotonin and dopamine uptake rats, transmitter concentrations and monoamine oxidase activities in various regions of the rat brain,” Biogenic Amines, 7, 1–10 (1990).
P. R. Solomon, A. Crider, J. W. Winkelman, et al., “Disrupted latent inhibition in the rat with chronic amphetamine or haloperidol-induced supersensitivity: relationship to schizophrenic attention disorder,” Biol. Psychiatry, 16, 519–537 (1981).
P. R. Solomon, C. A. Kiney, and D. R. Scott, “Disruption of latent inhibition following systemic administration of parachlorophenylalanine (PCPA),” Physiol. Behav., 20, 265–271 (1978).
P. R. Solomon, G. I. Nichols, J. M. Kiernan, et al., “Differential effects of lesions in medial and dorsal raphe of the rat: latent inhibition and septohippocampal serotonin levels,” J. Comp. Physiol. Psychol., 94, 145–154 (1980).
E. C. Warburton, M. H. Joseph, J. Feldon, I. Weiner, and J. A. Gray, “Antagonism of amphetamine-induced disruption of latent inhibition in rats by haloperidol and ondansetron: implications for a possible antipsychotic action of ondansetron,” Psychopharmacology, 114, 657–664 (1994).
I. Weiner, “Neural substrates of neural inhibition: the switching model,” Psychol. Bull., 108, 442–461 (1990).
I. Weiner and J. Feldon, “The switching model of latent inhibition: an update of neural substrates,” Behav. Brain Res., 88, 11–25 (1997).
I. Weiner, R. Tarrasch, and J. Feldon, “Basolateral amygdala lesions do not disrupt latent inhibition,” Behav. Brain Res., 72, 73–81 (1996).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Molodtsova, G.F. Differences in Serotonin and Dopamine Metabolism in the Rat Brain in Latent Inhibition. Neurosci Behav Physiol 33, 217–222 (2003). https://doi.org/10.1023/A:1022139028628
Issue Date:
DOI: https://doi.org/10.1023/A:1022139028628